Immunome stock hits 52-week high at 15.19 USD
PositiveFinancial Markets

Immunome's stock has reached a 52-week high of $15.19, reflecting strong investor confidence and positive market trends. This milestone is significant as it indicates the company's growth potential and could attract more investors, further boosting its market presence.
— Curated by the World Pulse Now AI Editorial System